Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Immunization rates hit record high in poor countries

29.01.2007
GAVI immunization programs in 2006 prevented 600,000 future deaths, new data shows -- GAVI to devote US $500 million to strengthen health systems in developing countries

New data from the World Health Organization (WHO) show that the GAVI Alliance, a groundbreaking global initiative to increase access to children’s vaccines, has brought immunisation rates to record highs in poor countries.

The WHO data, released today at the World Economic Forum’s annual meeting, project that since 2000, GAVI-funded immunisation programs in developing countries have prevented approximately 2.3 million future deaths, and that immunisations in 2006 alone prevented 600,000 future deaths.

Bill and Melinda Gates, co-chairs of the Bill & Melinda Gates Foundation, called the new data a highly encouraging sign of progress in global health. The Gates Foundation has committed a total of US$1.5 billion to support GAVI to date. GAVI has also received funding from 17 donor governments, including Germany, which recently committed €8 million (US$10.4 million).

"GAVI and its partners are leading a major turnaround in children’s health," said Melinda Gates. "When GAVI was founded, immunisation rates in poor countries were on the decline. Today, they are at an all-time high."

Since its inception in 2000, GAVI has committed US$2.6 billion to support national immunisation programs in more than 70 developing countries. According to the WHO projections released today, as a result of GAVI funding:

- 28 million more children have been protected against diphtheria, tetanus, and pertussis, helping to increase overall immunisation rates for these diseases from 63 percent in 1999 to 77 percent in 2006.

- 138 million more children have received new and under-used vaccines, such as those for hepatitis B, Hib, and yellow fever, helping to greatly increase immunisation coverage for these diseases. For example, the number of developing countries providing hepatitis B vaccine rose from 15 in 1999 to 61 in 2006.

"GAVI has demonstrated that with the right resources and leadership, it is possible to make dramatic health gains in poor countries," said Bill Gates. "We need to build on this success. No child should be denied access to lifesaving immunisations."

Despite GAVI’s progress, in 2005, an estimated 28 million children in developing countries were not immunised, and 2.5 million children died of vaccine-preventable diseases. To close this gap, WHO and UNICEF estimate that an additional US$10-15 billion will be needed for immunisation programs over the next decade. More funding will be needed to introduce vaccines that are currently in the development pipeline.

GAVI Commits US$500 Million to Strengthen Health Systems

In an effort to further increase global immunisation coverage, GAVI also announced today that it will invest US$500 million over five years to strengthen basic health systems in developing countries.

Weak health care infrastructure is often the main barrier to providing immunisations to children in developing countries, particularly in the poorest and most remote communities.

The new GAVI funding will provide flexible grants to developing countries for activities such as:

- Recruiting and training health care workers

- Building and strengthening systems to distribute vaccines and drugs

- Transporting health care workers and equipment
- Purchasing basic medical supplies, such as antibiotics and clean childbirth kits

"This is an exciting new direction for us," said Julian Lob-Levyt, Executive Secretary of GAVI. "Developing country leaders are telling us that in order for immunisation programs to be sustained, they need greater support for basic health infrastructure."

The first round of GAVI grants for strengthening health systems will be announced in February.

Jean-Pierre Le Calvez | EurekAlert!
Further information:
http://www.gavialliance.org

More articles from Studies and Analyses:

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

nachricht Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Researchers devise microreactor to study formation of methane hydrate

23.08.2017 | Materials Sciences

ShAPEing the future of magnesium car parts

23.08.2017 | Automotive Engineering

New insights into the world of trypanosomes

23.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>